Articles From: Lifeway Foods Announces Results for the Third Quarter of 2014 to Lightbridge Announces $5.04 Million Registered Direct Offering


Third Quarter Net Sales Increase 27% to $30.1 Million MORTON GROVE, Ill.
Sign-up for Lifeway Foods Announces Results for the Third Quarter of 2014 investment picks
Intercontinental Exchange (NYSE: ICE), the leading global network of exchanges and clearing houses, announced today that daily volume records were reached in Liffe Long Gilt futures and Ultra Long Gilt futures with 1,042,074 contracts and 5,118 contracts traded respectively on August 26, 2014.
Sign-up for Liffe Sets Daily Volume Record in Long Gilt and Ultra Long Gilt Futures, Long Gilt Futures Surpass 1,000,000 Daily Contract Mark investment picks
2014/9/2
NEW YORK , Sept 2, 2014 /PRNewswire/ -- China Housing & Land Development, Inc. ("CHLN") Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties in connection with the proposed going private transaction of CHLN (the "Transaction"). The Transaction includes a reverse stock split, whereby every 50,000 shares of CHLN's common stock will be converted into one share of common stock.
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of China Housing & Land Development, Inc., Cobra Electronics Corporation, Compuware Corporation, InterMune, Inc., International Rectifier Corporation, Peregrine Semiconductor Corporation and XRS Corporation investment picks
2014/10/31
Out-of-this-World Trip Made Possible Through a First of its Kind Partnership Between Paramount Pictures, Fandango, Motherboard and XCOR Aerospace LOS ANGELES , Oct.
Sign-up for LIFTING OFF TODAY, FANDANGO'S "INTERSTELLAR" TICKET-BUYERS CAN ENTER FOR A CHANCE TO WIN A TRIP TO THE FRONTIER OF SPACE ON XCOR'S LYNX SPACECRAFT investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Merck, known as MSD outside the United States and Canada, has received approval for NOXAFIL® (posaconazole) 300 mg Concentrate for Solution for Infusion from the European Medicines Agency (EMA). Ligand earns a $550,000 milestone payment as a result of the approval.
Sign-up for Ligand Earns Milestone Payment Triggered by EU Approval of Merck’s Captisol-enabled NOXAFIL® (posaconazole) Concentrate for Solution for Infusion investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced it has expanded its global license agreement with CURx Pharmaceuticals, Inc. to also include the development and commercialization of Ligand’s Captisol-enabled™ Lamotrigine program.
Sign-up for Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals, Inc. investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc reported the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorization for Revolade™ (eltrombopag), seeking an additional indication for the treatment of adult patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). SAA is a rare disorder in which the bone marrow fails to make enough new blood cells.
Sign-up for Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade™ (eltrombopag) investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc has received approval of a supplemental New Drug Application (sNDA) for the once-daily use of Promacta ® /Revolade ™ (eltrombopag) in patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). 1 SAA is a blood disorder where the bone marrow fails to make enough red blood cells, white blood cells and platelets.
Sign-up for Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta®/Revolade™ For Use in Patients with Severe Aplastic Anemia investment picks
At an Analyst Day event held earlier today in New York City, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reviewed the financial leverage in its business model, revenue growth opportunities and its portfolio of partnered assets and unpartnered development programs, as well as its Captisol formulation technology and its financial outlook through 2017.
Sign-up for Ligand Provides Highlights from Today’s Analyst Day Event investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today reported financial results for the three and nine months ended September 30, 2014, and provided an operating forecast and program updates.
Sign-up for Ligand Reports Third Quarter 2014 Financial Results investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported that total revenues for the third quarter of 2014 are expected to be approximately $15 million and that non-GAAP earnings per diluted share are expected to be between $0.33 and $0.37. This compares with prior guidance issued on August 4, 2014 for total revenues to be between $13 million and $14 million and for non-GAAP earnings per diluted share to be between $0.26 and $0.29. Ligand also expects total revenues for the fourth quarter to be between $22.5 million and $24.5 million.
Sign-up for Ligand Reports Third Quarter Revenues and Expected Diluted EPS investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, November 18, 2014 from 10:00 a.m. to 11:30 a.m. Eastern time (7:00 a.m. to 8:30 a.m. Pacific time) in New York City.
Sign-up for Ligand to Host Analyst Day on November 18th in New York City investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020852-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/30/11G020852/Clairvest-64124498660.jpg TORONTO, ON--(Marketwired - August 29, 2014) - Clairvest Group Inc. (TSX: CVG) ("CVG"), together with Clairvest Equity Partners III Limited Partnership ("CEP III", collectively "Clairvest"), announced today that Light Tower Rentals ("LTR") finalized its recapitalization by adding a group of institutional equity investors, following a US$330 million bond offering which was announced on July 21, 2014.
Sign-up for Light Tower Rentals Completes Recapitalization With New Equity Sponsors investment picks
MCLEAN, Va., Nov.
Sign-up for Lightbridge Announces $5.04 Million Registered Direct Offering investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Lifeway Foods Announces Results for the Third Quarter of 2014 to Lightbridge Announces $5.04 Million Registered Direct Offering
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent